Magic mushroom therapy tested for dual diagnosis of depression and alcoholism
NCT ID NCT07405606
Summary
This is a small, early-stage study to see if therapy sessions combined with a dose of psilocybin (the active compound in 'magic mushrooms') is safe and feasible for adults who have both major depression and alcohol use disorder. Researchers will compare a group receiving psilocybin to a group receiving a placebo (inactive substance) to look for differences in safety, side effects, and changes in symptoms of depression and alcohol use. The main goal is to gather initial data to see if this approach is worth studying in larger future trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.